SYRE FY 2024 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$209M

Net Income

-$208M

EPS (Diluted)

$-3.18

Cash Flow

Operating Cash Flow

-$157M

Free Cash Flow

-$157M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$608M

Total Liabilities

$91M

Stockholders' Equity

$518M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$886,000	-100.0%
Gross Profit	$0	$886,000	-100.0%
Operating Income	-$209M	-$242M	+13.9%
Net Income	-$208M	-$339M	+38.6%